Tag: Diabetes: Type II
Adiposity Genetic Risk Score Tied to Cardiometabolic Health
Genetic risk score from 11 variants linked to lower risk of type 2 diabetes, hypertension, heart disease
Exenatide Reduces Liver Fat in Type 2 Diabetes With Obesity
Reduction in epicardial adipose tissue and liver fat content with exenatide versus reference treatment
Research Finds Link Between Psoriasis, Obesity, T2DM
A genetic link is one theory for the possible association, researchers say
Review: Type 2 Diabetes Linked to Hearing Impairment
In older patients, age-related hearing impairment may mask the contribution of diabetes
Interrupting Prolonged Sitting Beneficial in Type 2 Diabetes
Brief bouts of light-intensity walking, simple resistance activities improve cardiometabolic factors
DiaRem Score Predicts Who Will Be Cured by RYGB Surgery
As DiaRem score increases, proportion of patients experiencing remission decreases
Lower CVD Mortality for Metformin Versus Sulfonylureas
Large analysis found up to 40 percent lower risk of heart disease mortality versus sulfonylureas
Metformin May Reduce Cancer Mortality Risk
Older women with diabetes and cancer taking metformin saw an increase in survival
CV Risk Not Significantly Different for GLP-1 Receptor Agonists
Findings based on large study in real-world, head-to-head comparison of other drugs
Exenatide Twice Daily Deemed Efficacious Across BMI Ranges
Significant weight loss with exenatide across BMI ranges; weight increased with comparators
